journal of chromatography a

metabolomics : official journal of the metabolomic society

bioanalysis

[1] Optimization of XCMS parameters for LC-MS metabolomics: an assessment of automated versus manual tuning and its effect on the final results.

[2] Biomarker profiling of vitamin responsive seizures: a potential tool to detect pediatric seizures of unknown aetiology.

[3] Accelerated benzene polycarboxylic acid analysis by liquid chromatography-time-of-flight-mass spectrometry for the determination of petrogenic and pyrogenic carbon.

[4] A UHPLC–MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (L-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4

[5] Stable isotope dilution assay for the accurate determination of tricaine in fish samples by HPLC–MS–MS

[6] Simultaneous determination of bisphenol A and its chlorinated derivatives in human plasma: Development, validation and application of a UHPLC–MS/MS method

[7] Simultaneous determination of the potent anti-tuberculosis regimen—Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC–MS/MS method coupled with 96-well format plate

[8] development and validation of spectrofluorimetric and lc–ms/ms methods for the determination of hesperidin in human plasma and pharmaceutical forms

[9] lc–ms characterization, anti-kinetoplastide and cytotoxic activities of natural products from eugenia jambolana lam. and eugenia uniflora

[10] lc–ms/ms assay for pitavastatin in human plasma and subsequent application to a clinical study in healthy chinese volunteers

[11] simultaneous quantification of ginsenoside rg1 and its metabolites by hplc–ms/ms: rg1 excretion in rat bile, urine and feces

[12] response to tsikas et al. comments on boelaert et al. determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: uplc–ms/ms versus elisa. toxins 2016, 8, 149

[13] development and validation of analytical method for naftopidil in human plasma by lc–ms/ms

[14] determination of 20(s)-protopanaxadiol in human plasma by hplc–ms/ms: application to a pharmacokinetic study

[15] determination of lercanidipine in human plasma by an improved uplc–ms/ms method for a bioequivalence study

[16] hplc–ms and hplc–ms/ms analysis of seven active constituents of xiao-xu-ming decoction and application to a pharmacokinetic study after oral administration to rat